Atopic asthma: T-cell response to corticosteroids.

Area of Science:

• Immunology
• Pulmonology
• Pharmacology

Background:

• Atopic asthma is linked to immune system imbalances, including T-lymphocyte subset dysregulation.
• Understanding T-cell subset responses to corticosteroids is crucial for asthma management.

Purpose of the Study:

• To investigate T-cell subset responses to systemic and inhaled corticosteroids in atopic asthmatic patients.
• To determine if atopic asthma is associated with baseline T-cell imbalances or abnormal corticosteroid responses.

Main Methods:

• A double-blind study involving 15 atopic asthmatic patients and 10 nonatopic subjects.
• Administration of oral prednisone (20 or 60 mg), beclomethasone dipropionate (BDP) aerosol, placebo, or BDP vehicle.
• Analysis of peripheral blood T-cell subsets (T4, T8, M1, Ia antigens) and T4/T8 ratio before and after administration.

Main Results:

• No baseline differences in T-cell subsets or T4/T8 ratio between atopic asthmatics and nonatopic subjects.
• Inhaled BDP and oral placebo did not alter T-cell values in either group.
• Systemic prednisone (20 and 60 mg) significantly reduced the T4/T8 ratio in atopic asthmatics but not in nonatopic subjects.

Conclusions:

• Atopic asthma is not characterized by baseline peripheral T-cell subset imbalances.
• Atopic asthmatic patients exhibit an abnormal T-cell subset response to systemic corticosteroids, but not to inhaled corticosteroids.